Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu,Michael D. Green,Shasha Li,Yilun Sun,Sara N. Journey,Jae Eun Choi,Syed Monem Rizvi,Angel Qin,Jessica J. Waninger,Xueting Lang,Zoey Chopra,Issam El Naqa,Jiajia Zhou,Yingjie Bian,Long Jiang,Alangoya Tezel,Jeremy Skvarce,Rohan K. Achar,Merna Sitto,Benjamin S. Rosen,Fengyun Su,Sathiya P. Narayanan,Xuhong Cao,Shuang Wei,Wojciech Szeliga,Linda Vatan,Charles Mayo,Meredith A. Morgan,Caitlin A. Schonewolf,Kyle Cuneo,Ilona Kryczek,Vincent T. Ma,Christopher D. Lao,Theodore S. Lawrence,Nithya Ramnath,Fei Wen,Arul M. Chinnaiyan,Marcin Cieslik,Ajjai Alva,Weiping Zou
DOI: https://doi.org/10.1038/s41591-020-1131-x
IF: 82.9
2021-01-01
Nature Medicine
Abstract:Metastasis is the primary cause of cancer mortality, and cancer frequently metastasizes to the liver. It is not clear whether liver immune tolerance mechanisms contribute to cancer outcomes. We report that liver metastases diminish immunotherapy efficacy systemically in patients and preclinical models. Patients with liver metastases derive limited benefit from immunotherapy independent of other established biomarkers of response. In multiple mouse models, we show that liver metastases siphon activated CD8<sup>+</sup> T cells from systemic circulation. Within the liver, activated antigen-specific Fas<sup>+</sup>CD8<sup>+</sup> T cells undergo apoptosis following their interaction with FasL<sup>+</sup>CD11b<sup>+</sup>F4/80<sup>+</sup> monocyte-derived macrophages. Consequently, liver metastases create a systemic immune desert in preclinical models. Similarly, patients with liver metastases have reduced peripheral T cell numbers and diminished tumoral T cell diversity and function. In preclinical models, liver-directed radiotherapy eliminates immunosuppressive hepatic macrophages, increases hepatic T cell survival and reduces hepatic siphoning of T cells. Thus, liver metastases co-opt host peripheral tolerance mechanisms to cause acquired immunotherapy resistance through CD8<sup>+</sup> T cell deletion, and the combination of liver-directed radiotherapy and immunotherapy could promote systemic antitumor immunity.
biochemistry & molecular biology,cell biology,medicine, research & experimental